Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Morrissey, SP; Deichmann, R; Syha, J; Simonis, C; Zettl, U; Archelos, JJ; Jung, S; Stodal, H; Lassmann, H; Toyka, KV; Haase, A; Hartung, HP.
Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies.
J Neuroimmunol. 1996; 69(1-2):85-93 Doi: 10.1016/0165-5728(96)00064-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Archelos-Garcia Juan-Jose
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The role of quantitative proton magnetic resonance imaging (MRI) for the evaluation of immunopathological lesions in the CNS was studied in adoptively transferred experimental allergic encephalomyelitis (AT-EAE). We utilized a recently established treatment model, inhibition of the cell adhesion molecule ICAM-1 by the monoclonal antibody 1A-29. The animals were scanned on days 3, 5 and 7 after injection of encephalitogenic T-cells, before and after bolus injection of Gd-DTPA by performing T1-measurements to assess the integrity of the blood-brain barrier (BBB). On day 7, immunohistochemistry was performed looking for T-cells, activated macrophages, and albumin staining. There was clinical evidence of partial inhibition of AT-EAE in rats treated with antibodies against ICAM-1. This finding was in line with a significantly reduced number of T-cells in the medulla. However, the number of activated macrophages and the distribution of albumin did not differ from untreated AT-EAE animals. The histological findings are in agreement with the MRI data before and after Gd-DTPA injection which were similar in treated and untreated AT-EAE rats on day 3 and 5. On day 7 after Gd-DTPA injection there was evidence of a delayed breakdown of the BBB in the treated rats. The observation of a dissociation of clinical and MRI findings, especially evidence of Gd-enhancement despite clinical improvement, may be important in the context of interpreting MRI studies in MS patients in treatment trials.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Antibodies, Monoclonal -
Blood-Brain Barrier -
Contrast Media -
Encephalomyelitis, Autoimmune, Experimental - prevention and control
Female - prevention and control
Gadolinium DTPA - prevention and control
Immunization, Passive - prevention and control
Intercellular Adhesion Molecule-1 - immunology
Magnetic Resonance Imaging - immunology
Organometallic Compounds - diagnostic use
Pentetic Acid - analogs and derivatives
Rats - analogs and derivatives
Rats, Inbred Lew - analogs and derivatives
Time Factors - analogs and derivatives

Find related publications in this database (Keywords)
multiple sclerosis
experimental allergic encephalomyelitis
magnetic resonance imaging
blood-brain barrier
adhesion molecules
© Med Uni Graz Impressum